Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 5, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

AIT-082 NeoTherapeutics Inc.

H Geerts1

  • 1Director of Cell Physiology, Life Sciences, Janssen Research Foundation, Turnhoutseweg 30, B-2340 Beerse, Belgium. hgeerts@janbelc1.ssw.jnj.com

Idrugs : the Investigational Drugs Journal
|May 10, 2008
PubMed
Summary

AIT-082, an orally-active nerve growth factor (NGF) agonist, demonstrated memory improvement in Alzheimer's patients and enhanced memory function in mice. Preclinical studies showed AIT-082 increased neurotrophic factors, suggesting potential for neurological disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Hashimoto encephalopathy as explanation of psychotic symptoms in an adolescent].

Tijdschrift voor psychiatrie·2018
Same author

Prediction of Efficacy of Vabicaserin, a 5-HT2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model.

CPT: pharmacometrics & systems pharmacology·2014
Same author

A quantitative system pharmacology computer model for cognitive deficits in schizophrenia.

CPT: pharmacometrics & systems pharmacology·2013
Same author

Has the time come for predictive computer modeling in CNS drug discovery and development?

CPT: pharmacometrics & systems pharmacology·2013
Same author

Sabeluzole accelerates neurite outgrowth in different neuronal cell lines.

Restorative neurology and neuroscience·2011
Same author

Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy.

Journal of neural transmission. Supplementum·2002

Area of Science:

  • Neuroscience
  • Pharmacology
  • Drug Development

Background:

  • Alzheimer's disease (AD), stroke, and motor neuron disease are debilitating neurological conditions.
  • Nerve growth factor (NGF) agonists are being investigated as potential therapeutic agents.
  • AIT-082 is an orally-active NGF agonist developed by NeoTherapeutics.

Purpose of the Study:

  • To evaluate the safety and efficacy of AIT-082 in Alzheimer's disease patients.
  • To assess the pharmacokinetic profile of AIT-082 in healthy elderly volunteers.
  • To investigate the effects of AIT-082 on memory function and neurotrophic factors in preclinical models.

Main Methods:

  • Phase II safety and efficacy trial in AD patients.
  • Phase I multiple-dose pharmacokinetic study in healthy elderly volunteers.
  • Preclinical studies in mice and rats involving memory tests and neurotrophic factor analysis.

Main Results:

  • AIT-082 improved memory in 60% of AD patients in a phase I/II trial.
  • Oral administration of AIT-082 was well-tolerated in healthy volunteers.
  • AIT-082 enhanced memory in mice, prevented age-related deficits, and restored memory after brain lesions.
  • AIT-082 increased neurotrophic factors (NT-3, CNTF, BDNF) in preclinical models.

Conclusions:

  • AIT-082 shows promise as a treatment for Alzheimer's disease and other neurological disorders.
  • The drug's ability to enhance memory and increase neurotrophic factors warrants further investigation.
  • AIT-082's oral bioavailability and tolerability support its continued development.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Jul 5, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024